Janssen, Halozyme In Global Drug Development Pact.

PHARMACEUTICAL industry; DRUG development; HALOZYME Therapeutics Inc.; JANSSEN Biotech Inc.; ELI Lilly & Co.; ADOCIA (Company); TRANSPOSAGEN Biopharmaceuticals Inc.

The article offers information on various collaborations and alliances within the pharmaceutical industry as of January 2015. These include the collaborations between Halozyme Therapeutics Inc. and Janssen Biotech Inc. for the development of the former's ENHANZE technology, Eli Lilly and Co. and Adocia for the development of BioChaperone Lispro insulin, and Transposagen Biopharmaceuticals Inc. and Janssen Biotech Inc. for the development of allogeneic Chimeric Antigen Receptor T-cells (CAR-T).